Needle-Free Injection Device Patent Application

ChangeBridge: EPO Bulletin - Medical Devices (A61M)

Published March 25th, 2026

Detected April 1st, 2026

Summary

European Patent Office published patent application EP3706834A1 by Conzima GmbH for a needle-free injection device using fluid injection technology. The application covers IPC classifications A61M 5/30, A61M 5/24, and A61M 5/315. Designated states include all major European jurisdictions (DE, FR, GB, IT, ES, NL, etc.).

View original document View source feed page

What changed

The EPO published Conzima GmbH's patent application EP3706834A1 for a method and device for needle-free fluid injection into a substrate. The application lists inventor Fritz Schmitt and covers technical classifications related to syringe mechanisms (A61M 5/30, A61M 5/24, A61M 5/315). The patent is designated for all 44 European member states and extension countries.

Patent publications do not create compliance obligations. This notice is informational for entities monitoring competitor intellectual property in the needle-free injection device space. Medical device manufacturers and healthcare providers should review the claims to assess potential licensing needs or freedom-to-operate considerations.

Source document (simplified)

← EPO Patent Bulletin

METHOD AND DEVICE FOR THE NEEDLE-FREE INJECTING OF FLUID INTO A SUBSTRATE

Publication EP3706834A1 Kind: A1 Mar 25, 2026

Applicants

Conzima GmbH

Inventors

SCHMITT, Fritz

IPC Classifications

A61M 5/30 20060101AFI20190517BHEP A61M 5/24 20060101ALI20190517BHEP A61M 5/315 20060101ALI20190517BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →